Skip to main content
Erschienen in: Supportive Care in Cancer 1/2024

01.01.2024 | Review

Interventions to improve quality of life in patients with head and neck cancers receiving radiation therapy: a scoping review

verfasst von: Shalini Ganesh Nayak, Anice George, Krishna Sharan, Baby S. Nayak, Naveen Salins

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

Quality of life (QOL) is impaired in patients with head and neck cancers (HNC) due to illness and treatment-associated morbidity. Although there is evidence from the studies on interventions’ role in improving QOL receiving radiation therapy, these are not systematically synthesised. In this scoping review, we searched and synthesised the evidence on interventions to improve the QOL and its impact among patients with HNCs.

Methods

This scoping review was conducted using the framework proposed by Arksey and O’Malley, and the extensions suggested by Levac et al. were incorporated. Two reviewers independently searched four electronic databases using key thesaurus and free-text terms, and the data was extracted, tabulated, synthesised and reported as categories.

Results

Seventy-nine papers reported various interventions of diverse nature such as pharmacological, physical, nutritional, complementary and alternative therapies, psychosocial, oral care related, laser and photobiomodulation therapies, rehabilitative, educational, technology-based, surgical, device-related and nurse lead interventions. Most studies reported clinically meaningful impact of interventions on QOL, although the outcome differences were often statistically insignificant. Few studies reported a combination of interventions to address the multidimensional concerns faced by patients with HNCs. None of the studies examined the impact of interventions on QOL among long-term survivors of HNCs.

Conclusion

As QOL concerns in patients with HNCs are multifaceted, more extensive studies with complex multi-component interventions and robust research designs are warranted.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
18.
Zurück zum Zitat Dunne S, Mooney O, Coffey L, et al (2017) Psychological variables associated with quality of life following primary treatment for head and neck cancer: a systematic review of the literature from 2004 to 2015. Psychooncology 26:149–160. https://doi.org/10.1002/pon.4109 Dunne S, Mooney O, Coffey L, et al (2017) Psychological variables associated with quality of life following primary treatment for head and neck cancer: a systematic review of the literature from 2004 to 2015. Psychooncology 26:149–160. https://​doi.​org/​10.​1002/​pon.​4109
19.
Zurück zum Zitat Hu Q, Zhao D (2021) Effects of resistance exercise on complications, cancer-related fatigue and quality of life in nasopharyngeal carcinoma patients undergoing chemoradiotherapy: a randomised controlled trial. Eur J Cancer Care (Engl) 30:1–8. https://doi.org/10.1111/ecc.13355CrossRef Hu Q, Zhao D (2021) Effects of resistance exercise on complications, cancer-related fatigue and quality of life in nasopharyngeal carcinoma patients undergoing chemoradiotherapy: a randomised controlled trial. Eur J Cancer Care (Engl) 30:1–8. https://​doi.​org/​10.​1111/​ecc.​13355CrossRef
21.
Zurück zum Zitat Samuel SR, Arun Maiya G, Babu AS, Vidyasagar MS (2013) Effect of exercise training on functional capacity & quality of life in head & neck cancer patients receiving chemoradiotherapy. Indian J Med Res 137:515–520PubMedPubMedCentral Samuel SR, Arun Maiya G, Babu AS, Vidyasagar MS (2013) Effect of exercise training on functional capacity & quality of life in head & neck cancer patients receiving chemoradiotherapy. Indian J Med Res 137:515–520PubMedPubMedCentral
28.
Zurück zum Zitat Tricco AC, Lillie E, Zarin W et al (2018) PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 169:467–473CrossRefPubMed Tricco AC, Lillie E, Zarin W et al (2018) PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 169:467–473CrossRefPubMed
30.
Zurück zum Zitat Peters M, Godfrey CM, Khalil H, Mcinerney P (2017) Chapter 11· September 2017. In: 2017 Guidance for the Conduct of JBI Scoping Reviews. pp 1–23 Peters M, Godfrey CM, Khalil H, Mcinerney P (2017) Chapter 11· September 2017. In: 2017 Guidance for the Conduct of JBI Scoping Reviews. pp 1–23
34.
36.
Zurück zum Zitat Ryu JK, Swann S, LeVeque F et al (2007) The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective Phase III study by Radiation Therapy Oncology Group 9901. Int J Radiat Oncol Biol Phys 67:643–650. https://doi.org/10.1016/j.ijrobp.2006.09.043CrossRefPubMed Ryu JK, Swann S, LeVeque F et al (2007) The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective Phase III study by Radiation Therapy Oncology Group 9901. Int J Radiat Oncol Biol Phys 67:643–650. https://​doi.​org/​10.​1016/​j.​ijrobp.​2006.​09.​043CrossRefPubMed
44.
Zurück zum Zitat Hoffman KE, Pugh S, James JL et al (2015) The impact of concurrent granulocyte macrophage-colony stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controled radiation therapy oncology group 9901 trial. Qual Life Res 23:1841–1858. https://doi.org/10.1007/s11136-014-0628-5.THECrossRef Hoffman KE, Pugh S, James JL et al (2015) The impact of concurrent granulocyte macrophage-colony stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controled radiation therapy oncology group 9901 trial. Qual Life Res 23:1841–1858. https://​doi.​org/​10.​1007/​s11136-014-0628-5.​THECrossRef
46.
48.
49.
51.
Zurück zum Zitat Zhao SG, Alexander NB, Djuric Z, et al (2016) Maintaining physical activity during head and neck cancer treatment: results of a pilot controlled trial. Head Neck E1086–1096 https://doi.org/10.1002/HED Zhao SG, Alexander NB, Djuric Z, et al (2016) Maintaining physical activity during head and neck cancer treatment: results of a pilot controlled trial. Head Neck E1086–1096 https://​doi.​org/​10.​1002/​HED
52.
Zurück zum Zitat Kumar R, Gupta H, Konwar K et al (2015) Impact of early dysphagia intervention on swallowing function and quality of life in head and neck cancer patients treated with intensity-modulated radiation therapy or image guided radiation therapy with or without surgery/chemotherapy. Asian J Oncol 01:037–043. https://doi.org/10.4103/2454-6798.165109CrossRef Kumar R, Gupta H, Konwar K et al (2015) Impact of early dysphagia intervention on swallowing function and quality of life in head and neck cancer patients treated with intensity-modulated radiation therapy or image guided radiation therapy with or without surgery/chemotherapy. Asian J Oncol 01:037–043. https://​doi.​org/​10.​4103/​2454-6798.​165109CrossRef
59.
63.
65.
Zurück zum Zitat June Corry F, Poon W, McPhee N, et al (2009) Prospective study of percutaneous endoscopic gastrostomy tubes versus nasogastric tubes for enteral feeding in patients with head and neck cancer undergoing (chemo)radiation. Head Neck 867–876 https://doi.org/10.1002/HED June Corry F, Poon W, McPhee N, et al (2009) Prospective study of percutaneous endoscopic gastrostomy tubes versus nasogastric tubes for enteral feeding in patients with head and neck cancer undergoing (chemo)radiation. Head Neck 867–876 https://​doi.​org/​10.​1002/​HED
68.
Zurück zum Zitat Pramyothin P, Manyanont S, Trakarnsanga A et al (2016) A prospective study comparing prophylactic gastrostomy to nutritional counselling with a therapeutic feeding tube if required in head and neck cancer patients undergoing chemoradiotherapy in Thai real-world practice. J Hum Nutr Diet 29:768–776. https://doi.org/10.1111/jhn.12377CrossRefPubMed Pramyothin P, Manyanont S, Trakarnsanga A et al (2016) A prospective study comparing prophylactic gastrostomy to nutritional counselling with a therapeutic feeding tube if required in head and neck cancer patients undergoing chemoradiotherapy in Thai real-world practice. J Hum Nutr Diet 29:768–776. https://​doi.​org/​10.​1111/​jhn.​12377CrossRefPubMed
70.
Zurück zum Zitat Pottel L, Lycke M, Boterberg T, et al (2014) Echium oil is not protective against weight loss in head and neck cancer patients undergoing curative radio(chemo)therapy: a randomised-controlled trial. BMC Complement Altern Med 14 https://doi.org/10.1186/1472-6882-14-382 Pottel L, Lycke M, Boterberg T, et al (2014) Echium oil is not protective against weight loss in head and neck cancer patients undergoing curative radio(chemo)therapy: a randomised-controlled trial. BMC Complement Altern Med 14 https://​doi.​org/​10.​1186/​1472-6882-14-382
75.
Zurück zum Zitat Hsu PY, Yang SH, Tsang NM, et al (2016) Efficacy of traditional Chinese medicine in xerostomia and quality of life during radiotherapy for head and neck cancer: a prospective pilot study. Evidence-based Complement Altern Med 2016 https://doi.org/10.1155/2016/8359251 Hsu PY, Yang SH, Tsang NM, et al (2016) Efficacy of traditional Chinese medicine in xerostomia and quality of life during radiotherapy for head and neck cancer: a prospective pilot study. Evidence-based Complement Altern Med 2016 https://​doi.​org/​10.​1155/​2016/​8359251
76.
Zurück zum Zitat Pollard A, Burchell JL, Castle D et al (2017) Individualised mindfulness-based stress reduction for head and neck cancer patients undergoing radiotherapy of curative intent: a descriptive pilot study. Eur J Cancer Care (Engl) 26:1–11. https://doi.org/10.1111/ecc.12474CrossRef Pollard A, Burchell JL, Castle D et al (2017) Individualised mindfulness-based stress reduction for head and neck cancer patients undergoing radiotherapy of curative intent: a descriptive pilot study. Eur J Cancer Care (Engl) 26:1–11. https://​doi.​org/​10.​1111/​ecc.​12474CrossRef
77.
Zurück zum Zitat Britton B, Baker AL, Wolfenden L et al (2019) Eating as treatment (EAT): a stepped-wedge, randomized controlled trial of a health behavior change intervention provided by dietitians to improve nutrition in patients with head and neck cancer undergoing radiation therapy (TROG 12.03). Int J Radiat Oncol Biol Phys 103:353–362. https://doi.org/10.1016/j.ijrobp.2018.09.027CrossRefPubMed Britton B, Baker AL, Wolfenden L et al (2019) Eating as treatment (EAT): a stepped-wedge, randomized controlled trial of a health behavior change intervention provided by dietitians to improve nutrition in patients with head and neck cancer undergoing radiation therapy (TROG 12.03). Int J Radiat Oncol Biol Phys 103:353–362. https://​doi.​org/​10.​1016/​j.​ijrobp.​2018.​09.​027CrossRefPubMed
78.
Zurück zum Zitat Li C, Duan J (2021) Effect of high-quality nursing intervention on psychological emotion, life quality and nursing satisfaction of patients with nasopharyngeal carcinoma undergoing radiotherapy. Am J Transl Res 13:4928–4938PubMedPubMedCentral Li C, Duan J (2021) Effect of high-quality nursing intervention on psychological emotion, life quality and nursing satisfaction of patients with nasopharyngeal carcinoma undergoing radiotherapy. Am J Transl Res 13:4928–4938PubMedPubMedCentral
87.
89.
98.
102.
Zurück zum Zitat Ingargiola R, De Santis MC, Iacovelli NA et al (2020) A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients. Radiat Oncol 15:1–12. https://doi.org/10.1186/s13014-020-01633-0CrossRef Ingargiola R, De Santis MC, Iacovelli NA et al (2020) A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients. Radiat Oncol 15:1–12. https://​doi.​org/​10.​1186/​s13014-020-01633-0CrossRef
106.
Zurück zum Zitat Farrugia M, Erickson K, Wendel E, et al (2021) Change in physical performance correlates with decline in quality of life and frailty status in head and neck cancer patients undergoing radiation with and without chemotherapy. Cancers (Basel) 13 https://doi.org/10.3390/cancers13071638 Farrugia M, Erickson K, Wendel E, et al (2021) Change in physical performance correlates with decline in quality of life and frailty status in head and neck cancer patients undergoing radiation with and without chemotherapy. Cancers (Basel) 13 https://​doi.​org/​10.​3390/​cancers13071638
111.
Zurück zum Zitat Tabish SA (2008) Complementary and alternative healthcare: is it evidence-based? Int J Heal Sci 2:1–143 Tabish SA (2008) Complementary and alternative healthcare: is it evidence-based? Int J Heal Sci 2:1–143
Metadaten
Titel
Interventions to improve quality of life in patients with head and neck cancers receiving radiation therapy: a scoping review
verfasst von
Shalini Ganesh Nayak
Anice George
Krishna Sharan
Baby S. Nayak
Naveen Salins
Publikationsdatum
01.01.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 1/2024
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-023-08197-1

Weitere Artikel der Ausgabe 1/2024

Supportive Care in Cancer 1/2024 Zur Ausgabe

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.